• Will immunotherapy really change radiotherapy?

    Our opinion is to redesign a new framework in a way radiotherapy is delivered to interact most optimally with immunotherapy rather than directly killing as many cells as possible with radiation.

    Authors : Philippe Lambin, Relinde Lieverse

    Read the publication
  • How Advances in Imaging Will Affect Precision Radiation Oncology.

    Int J Radiat Oncol Biol Phys. 2018 Jun 1

    Authors : Jaffray DA, Das S, Jacobs PM, Jeraj R, Lambin P.

    Read the publication
  • Fractal-based radiomic approach to predict complete pathological response after chemo-radiotherapy in rectal cancer.

    Radiol Med. 2018 Apr

    Authors : Cusumano D, Dinapoli N, Boldrini L, Chiloiro G, Gatta R, Masciocchi C, Lenkowicz J, Casà C, Damiani A, Azario L, Van Soest J, Dekker A, Lambin P, De Spirito M, Valentini V.

    Read the publication
  • Non-linear conversion of HX4 uptake for automatic segmentation of hypoxic volumes and dose prescription.

    Acta Oncol. 2018 Apr

    Authors : Ureba A, Lindblom E, Dasu A, Uhrdin J, Even AJG, van Elmpt W, Lambin P, Wersäll P, Toma-Dasu I.

    Read the publication
  • Multi-Scale Modeling and Oxygen Impact on Tumor Temporal Evolution: Application on Rectal Cancer During Radiotherapy.

    IEEE Trans Med Imaging. 2018 Apr

    Authors : Apeke S, Gaubert L, Boussion N, Lambin P, Visvikis D, Rodin V, Redou P.

    Read the publication
  • Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study.

    Br J Radiol. 2018 Mar

    Authors : Leijenaar RT, Bogowicz M, Jochems A, Hoebers FJ, Wesseling FW, Huang SH, Chan B, Waldron JN, O'Sullivan B, Rietveld D, Leemans CR, Brakenhoff RH, Riesterer O, Tanadini-Lang S, Guckenberger M, Ikenberg K, Lambin P.

    Read the publication
  • 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.

    PLoS One. 2018 Mar 1

    Authors : Carvalho S, Leijenaar RTH, Troost EGC, van Timmeren JE, Oberije C, van Elmpt W, de Geus-Oei LF, Bussink J, Lambin P.

    Read the publication
  • Results and adverse events of personalized peptide receptor radionuclide therapy with Yttrium and Lutetium in 1048 patients with neuroendocrine neoplasms.

    Oncotarget. 2018 Feb 15

    Authors : Baum RP, Kulkarni HR, Singh A, Kaemmerer D, Mueller D, Prasad V, Hommann M, Robiller FC, Niepsch K, Franz H, Jochems A, Lambin P, Hörsch D.

    Read the publication
  • A prediction model for early death in non-small cell lung cancer patients following curative-intent chemoradiotherapy.

    Acta Oncol. 2018 Feb

    Authors : Jochems A, El-Naqa I, Kessler M, Mayo CS, Jolly S, Matuszak M, Faivre-Finn C, Price G, Holloway L, Vinod S, Field M, Barakat MS, Thwaites D, de Ruysscher D, Dekker A, Lambin P.

    Read the publication
  • Evidence on the efficacy of primary radiosurgery or stereotactic radiotherapy for drug-resistant non-neoplastic focal epilepsy in adults: A systematic review.

    Seizure. 2018 Feb

    Authors : Eekers DBP, Pijnappel EN, Schijns OEMG, Colon A, Hoeben A, Zindler JD, Postma AA, Hoffmann AL, Lambin P, Troost EGC.

    Read the publication
  • Towards a Clinical Decision Support System for External Beam Radiation Oncology Prostate Cancer Patients: Proton vs. Photon Radiotherapy? A Radiobiological Study of Robustness and Stability.

    Cancers (Basel). 2018 Feb 18

    Authors : Walsh S, Roelofs E, Kuess P, van Wijk Y, Vanneste B, Dekker A, Lambin P, Jones B, Georg D, Verhaegen F.

    Read the publication
  • The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses.

    Oncoimmunology. 2018 Jan 16

    Authors : Rekers NH, Olivo Pimentel V, Yaromina A, Lieuwes NG, Biemans R, Zegers CML, Germeraad WTV, Van Limbergen EJ, Neri D, Dubois LJ, Lambin P

    Read the publication
  • Novel tools to assist neoepitope targeting in personalized cancer immunotherapy.

    Ann Oncol. 2017 Dec 1

    Authors : Saini SK, Rekers N, Hadrup SR

    Read the publication
  • The posterior cerebellum, a new organ at risk?

    Clin Transl Radiat Oncol. 2017 Nov

    Authors : Eekers DBP, In 't Ven L, Deprez S, Jacobi L, Roelofs E, Hoeben A, Lambin P, de Ruysscher D, Troost EGC.

    Read the publication
  • Combining radiotherapy with immunotherapy: the past, the present and the future.

    Br J Radiol. 2017 Aug

    Authors : Van Limbergen EJ, De Ruysscher DK, Olivo Pimentel V, Marcus D, Berbee M, Hoeben A, Rekers N, Theys J, Yaromina A, Dubois LJ, Lambin P

    Read the publication
  • Cancer immunotherapy: from the lab to clinical applications-Potential impact on cancer centres' organisation.

    Ecancermedicalscience. 2016 Nov 10

    Authors : Cairns L, Aspeslagh S, Anichini A, Kyte JA, Blank C, Ascierto P, Rekers N, Straten PT, Awada A

    Read the publication
  • Combination of radiotherapy with the immunocytokine L19-IL2: Additive effect in a NK cell dependent tumour model.

    Radiother Oncol. 2015 Sep

    Authors : Rekers NH, Zegers CM, Yaromina A, Lieuwes NG, Biemans R, Senden-Gijsbers BL, Losen M, Van Limbergen EJ, Germeraad WT, Neri D, Dubois L, Lambin P

    Read the publication
  • Radiotherapy combined with the immunocytokine L19-IL2 provides long-lasting antitumor effects.

    Clin Cancer Res. 2015 Mar 1

    Authors : Zegers CM, Rekers NH, Quaden DH, Lieuwes NG, Yaromina A, Germeraad WT, Wieten L, Biessen EA, Boon L, Neri D, Troost EG, Dubois LJ, Lambin P

    Read the publication
  • Stereotactic ablative body radiotherapy combined with immunotherapy: present status and future perspectives.

    Cancer Radiother. 2014 Oct

    Authors : Rekers NH, Troost EG, Zegers CM, Germeraad WT, Dubois LJ, Lambin P

    Read the publication

Stay informed?

If you want to stay informed about ImmunoSABR project, please subscribe to our newsletter.